Dr. Youn Kim

Anesthesiology
1301 N Rose Dr, 
Placentia, CA 
Clinical Trials:Currently Recruiting for 1 Trial
1301 N Rose Dr, 
Placentia, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Youn Kim is an Anesthesiologist in Placentia, California. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are T-Cell Lymphoma, Small Lymphocytic Lymphoma (SLL), Discoid Lupus Erythematosus (DLE), and Arteriovenous Malformation.

His clinical research consists of co-authoring 234 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Anesthesiology
Licenses
Anesthesiology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Uci Health-Placentia Linda
1301 N Rose Dr, Placentia, CA 92870

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Enrollment Status: Recruiting
Publish Date: October 02, 2024
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
Enrollment Status: Terminated
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: TTI-621, Rituximab
Study Phase: Phase 1
A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)
A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Other, Biological
Study Drugs: Interferon Gamma-1b, Pembrolizumab
Study Phase: Phase 2
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Drug, Radiation
Study Drugs: Anti-Thymocyte Globulin, Cyclosporine
Study Phase: Phase 2
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

234 Total Publications

A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification.
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification.
Journal: Blood
Published: April 16, 2025
Similar Doctors
Experienced in Arteriovenous Malformation
Dr. Chih Lee
Anesthesiology
Experienced in Arteriovenous Malformation
Dr. Chih Lee
Anesthesiology

Joseph Loewenbein MD A Medical Corporation

3530 Wilshire Blvd Ste 350, 
Los Angeles, CA 
 (29.7 miles away)
213-637-3703
Experience:
37+ years
Languages Spoken:
English

Chih Lee is an Anesthesiologist in Los Angeles, California. Dr. Lee has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Arteriovenous Malformation and Intestinal Cancer.

Experienced in Arteriovenous Malformation
Dr. Lorraine Kaelin
Anesthesiology
Experienced in Arteriovenous Malformation
Dr. Lorraine Kaelin
Anesthesiology

St Joseph Hospital Of Orange

1100 W Stewart Dr, 
Orange, CA 
 (7.4 miles away)
714-633-9111
Languages Spoken:
English
See accepted insurances

Lorraine Kaelin is an Anesthesiologist in Orange, California. Dr. Kaelin is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. Her top areas of expertise are Arteriovenous Malformation and Ptosis.

Experienced in Arteriovenous Malformation
Dr. Earl Strum
Anesthesiology
Experienced in Arteriovenous Malformation
Dr. Earl Strum
Anesthesiology

Keck Hospital Of USC

1500 San Pablo St, 
Los Angeles, CA 
 (23.9 miles away)
323-442-8500
Languages Spoken:
English
See accepted insurances

Earl Strum is an Anesthesiologist in Los Angeles, California. Dr. Strum is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Arteriovenous Malformation and Gallbladder Disease.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kim's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile